GB1322095A - Compositions containing l-dopa,2-imino-5-phenyl-4-oxazolidinone and an aluminum or alkaline earth metal salt or base used to treat parkinsons disease - Google Patents

Compositions containing l-dopa,2-imino-5-phenyl-4-oxazolidinone and an aluminum or alkaline earth metal salt or base used to treat parkinsons disease

Info

Publication number
GB1322095A
GB1322095A GB5023371A GB5023371A GB1322095A GB 1322095 A GB1322095 A GB 1322095A GB 5023371 A GB5023371 A GB 5023371A GB 5023371 A GB5023371 A GB 5023371A GB 1322095 A GB1322095 A GB 1322095A
Authority
GB
United Kingdom
Prior art keywords
oxazolidinone
earth metal
alkaline earth
salt
dopa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5023371A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of GB1322095A publication Critical patent/GB1322095A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

1322095 Anti-parkinson compositions ABBOTT LABORATORIES 28 Oct 1971 [23 Nov 1970 27 Jan 1971] 50233/71 Heading A5B A composition for treating Parkinson's disease comprises (a) l-dopa, (b) 2-imino-5-phenyl- 4-oxazolidinone or a salt thereof and (c) 0.05 mole of an alkaline earth metal or aluminium base or salt per mole of oxazolidinone. The oxazolidinone salt may be an alkali or alkaline earth metal salt. The alkaline earth metal base or salt (c) may be Mg(OH) 2 or a magnesium salt. The composition may also include a carrier. It may be in unit dose form.
GB5023371A 1970-11-23 1971-10-28 Compositions containing l-dopa,2-imino-5-phenyl-4-oxazolidinone and an aluminum or alkaline earth metal salt or base used to treat parkinsons disease Expired GB1322095A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9216670A 1970-11-23 1970-11-23
US11025671A 1971-01-27 1971-01-27

Publications (1)

Publication Number Publication Date
GB1322095A true GB1322095A (en) 1973-07-04

Family

ID=26785355

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5023371A Expired GB1322095A (en) 1970-11-23 1971-10-28 Compositions containing l-dopa,2-imino-5-phenyl-4-oxazolidinone and an aluminum or alkaline earth metal salt or base used to treat parkinsons disease

Country Status (5)

Country Link
AU (1) AU3509971A (en)
CA (1) CA964581A (en)
DE (1) DE2157881A1 (en)
FR (1) FR2115239B1 (en)
GB (1) GB1322095A (en)

Also Published As

Publication number Publication date
AU3509971A (en) 1973-05-03
DE2157881A1 (en) 1972-06-08
CA964581A (en) 1975-03-18
FR2115239A1 (en) 1972-07-07
FR2115239B1 (en) 1974-11-15

Similar Documents

Publication Publication Date Title
CA959590A (en) Acrylic modifiers for polycarbonamides
IL36299A0 (en) 3-octadecyloxypropyl-2'-trimethylammoniumethyl phosphate,its preparation and pharmaceutical compositions containing it
GB1388358A (en) Taste-improving formulations of oral penicillins
ES437674A1 (en) Grain refining of aluminum
CA934270A (en) Vanne de detente d'un fluide sous pression
GB1322095A (en) Compositions containing l-dopa,2-imino-5-phenyl-4-oxazolidinone and an aluminum or alkaline earth metal salt or base used to treat parkinsons disease
CA955426A (en) Compression resistant zinc base alloy
CA961041A (en) 1-methyl-3-alkoxymethyl-5,5-disub-stituted barbituric acid compounds and therapeutic compositions containing same
CA956756A (en) Dispositif de haubannage pour le lancement d'un ouvrage de franchissement
CA986527A (en) Sels d'indamines utilisables pour la teinture des fibres keratiniques, en particulier des cheveux humains
CA944929A (en) Titanium carbide preparation
ES386130A1 (en) Aminoethanesulfonic acid derivative
IL38094A (en) Selected 5-substituted-5-phenylalkyl barbituric acids,processes for preparing the same and therapeutic compositions containing the same
CA943309A (en) Method for improving the fracture toughness of metals and alloys
ZA717146B (en) Combination of l-dopa,2-imino-5-phenyl-4-oxazolidinone and an aluminum or alkaline earth metal salt or base used to treat parkinson's disease
CA942612A (en) Embout permettant l'application d'un produit fluide sur des cheveux
GB1283810A (en) Magnesium aspartate hydrohalides
CA843364A (en) Titanium steel alloy
ES406982A2 (en) Procedure for the electrolytic dyeing of aluminum objects or aluminum alloy. (Machine-translation by Google Translate, not legally binding)
IL37702A (en) Boric acid complexes of optionally n-substituted dopamine compounds,the corresponding n-substituted dopamine compounds and pharmaceutical compositions containing the latter
GB1403674A (en) Metal salts of 1,4-dithiol-2,3-butanediol
CA925875A (en) Process for producing 2-butyl-n, n'-diphenyl-malono-monohydrazide and its calcium, magnesium and aluminium salts
AU451774B2 (en) Amino derived from 3,4-ethylenedioxy- -phenylacetonitrile and its non-toxic acid addition salts
CA854122A (en) Titanium alloy
CA838088A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 5((.alpha.,.alpha.,.alpha.,-TRIFLUORO-M-TOLYLOXY)-METHYL)-2-OXAZOLIDINETHIONE

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees